Boston An independent LDT provider


Immunovia’s pipeline today covers two main projects that are in early development phase:

  1. Lung cancer
  2. Autoimmune diseases with focus on Rheumatoid Arthritis (RA)

Research projects often go through several iterations of research studies before Immunovia can make a decision to advance the project into development. Not all research projects will be successful and timelines are unpredictable, therefore we will report on the research projects when significant development occurs.